Abstract
Background
This systematic review and meta-analysis aimed to evaluate the effectiveness of radioactive iodine (RAI) remnant ablation for thyroid cancer-related outcomes of patients with papillary thyroid microcarcinoma (PTMC).
Methods
A systematic literature search of PubMed, EMBASE OvidSP, and EBSCO was conducted. Studies were selected that provided multivariable analysis of the effectiveness of RAI ablation or provided specific data of a 10 years history of thyroid cancer-related outcomes in patients that presented with PTMC.
Results
Nineteen studies met the inclusion criteria. A multivariable analysis of the effectiveness of RAI ablation for any recurrence or thyroid cancer-related mortality in patients with PTMC was performed in several studies, among which only one study reported a positive result. Furthermore, for PTMC patients treated by total or near-total thyroidectomy (TT/NT), with or without RAI ablative therapy, the meta-analysis suggested that RAI ablation did not decrease the 10 years history of any tumor recurrence (relative risk [RR] 0.96; 95 % confidence interval [CI] 0.63–1.48; P = 0.87), locoregional recurrence (RR 1.15; 95 % CI 0.75–1.76; P = 0.51), distant metastases (RR 0.32; 95 % CI 0.08–1.32; P = 0.11) or thyroid cancer-related mortality (RR 0.76; 95 % CI 0.22–2.63; P = 0.66).
Conclusions
With regard to multivariable analyses, there was almost no positive treatment effect of RAI ablation noted for patients with PTMC. For PTMC patients already treated by TT/NT, incremental RAI ablation may not be beneficial at decreasing the 10 years recurrence of PTMC or incidence of thyroid cancer-related mortality.
Similar content being viewed by others
References
Hedinger C, Williams E, Sobin L (1988) Histological typing of thyroid tumours. World Health Organisation histological classification of tumors, 2nd edn. Springer-Verlag, Berlin, pp 9–10
Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322
Arora N, Turbendian HK, Kato MA et al (2009) Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 19:473–477
Wartofsky L (2012) Management of papillary microcarcinoma: primum non nocere? J Clin Endocrinol Metab 97:1169–1172
Haymart MR, Banerjee M, Stewart AK et al (2011) Use of radioactive iodine for thyroid cancer. JAMA 06:721–728
Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214
Pacini F, Castagna MG, Brilli L et al (2012) Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23:vii110–vii119
Jung TS, Kim TY, Kim KW et al (2007) Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocr J 54:265–274
Sawka AM, Thephamongkhol K, Brouwers MA et al (2004) Systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 89:3668–3676
Sacks W, Fung CH, Chang JT et al (2010) The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008. Thyroid 20:1235–1245
Cappelli C, Castellano M, Braga M et al (2007) Aggressiveness and outcome of papillary thyroid carcinoma (PT C) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol 95:555–560
Ito Y, Miyauchi A, Inoue H et al (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34:28–35. doi:10.1007/s00268-009-0303-0
Sugitani I, Toda K, Yamada K et al (2010) Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34:1222–1231. doi:10.1007/s00268-009-0359-x
Lee J, Park JH, Lee CR et al (2013) Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching. Thyroid 23:1408–1415
Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341
Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34
Castillo JJ, Dalia S, Pascual SK (2010) Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood 116:2897–2907
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
Langan D, Higgins JPT, Gregory W et al (2012) Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J Clin Epidemiol 65:511–519
Lau J, Ioannidis JPA, Terrin N et al (2006) The case of the misleading funnel plot. BMJ 333:597–600
Pedrazzini L, Baroli A, Marzoli L et al (2013) Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Minerva Endocrinol 38:269–279
Mihailovic J, Stefanovic L, Stankovic R (2013) Influence of initial treatment on the survival and recurrence in patients with differentiated thyroid microcarcinoma. Clin Nucl Med 38:332–338
Kim HJ, Kim NK, Choi JH et al (2013) Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma. Clin Endocrinol 78:614–620
Riss JC, Peyrottes I, Chamorey E et al (2012) Prognostic impact of tumour multifocality in thyroid papillary microcarcinoma based on a series of 160 cases. Eur Ann Otorhinolaryngol Head Neck Dis 129:175–178
Gershinsky M, Barnett-Griness O, Stein N et al (2012) Total versus hemithyroidectomy for microscopic papillary thyroid cancer. J Endocrinol Invest 35:464–468
Neuhold N, Schultheis A, Hermann M et al (2011) Incidental papillary microcarcinoma of the thyroid—further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up. Ann Surg Oncol 18:3430–3436
Moon HJ, Kim EK, Chung WY et al (2011) Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?[J]. Ann Surg Oncol 18:1916–1923
Mercante G, Frasoldati A, Pedroni C et al (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707–716
Pisanu A, Reccia I, Nardello O et al (2009) Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J Surg 33:460–468. doi:10.1007/s00268-008-9870-8
Kim TY, Hong SJ, Kim JM et al (2008) Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer 8:296–307
Hay ID, Hutchinson ME, Gonzalez-Losada T et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980–988
Gülben K, Berberoğlu U, Çelen O et al (2008) Incidental papillary microcarcinoma of the thyroid—factors affecting lymph node metastasis. Langenbecks Arch Surg 393:25–29
Pelizzo MR, Boschin IM, Toniato A et al (2006) Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 32:1144–1148
Cheema Y, Olson S, Elson D et al (2006) What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? J Surg Res 134:160–162
Lo CY, Chan WF, Lang BHH et al (2006) Papillary microcarcinoma: is there any difference between clinically overt and occult tumors. World J Surg 30:759–766. doi:10.1007/s00268-005-0363-8
Roti E, Rossi R, Trasforini G et al (2006) Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91:2171–2178
Chow SM, Law SCK, Chan JKC et al (2003) Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40
Appetecchia M, Scarcello G, Pucci E et al (2002) Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res 21:159–164
Baudin E, Travagli JP, Ropers J et al (1998) Microcarcinoma of the thyroid gland. Cancer 83:553–559
Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407
Zhang L, Wei WJ, Ji QH et al (2012) Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab 97:1250–1257
Xing M, Haugen BR, Schlumberger M (2013) Progress in molecular-based management of differentiated thyroid cancer. Lancet 381:1058–1069
Nucera C, Pontecorvi A (2012) Clinical outcome, role of BRAFV600E, and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer? Front Endocrinol 3:33
Acknowledgments
The authors acknowledge the helpful methodological advice of Dr. Xiaochun Chou (Shanghai Jiao Tong University).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Authors declare that there are no conflicts, either perceived or real, with respect to this article.
Additional information
Guangfu Hu and Wei Zhu have contributed equally to this work and co-first authors.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hu, G., Zhu, W., Yang, W. et al. The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis. World J Surg 40, 100–109 (2016). https://doi.org/10.1007/s00268-015-3346-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-015-3346-4